quinoline has been researched along with Parkinson Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves, D; Araujo, SM; Bortolotto, VC; de Freitas Couto, S; do Sacramento, M; La Rosa Novo, D; Meichtry, LB; Mesko, MF; Pinheiro, FC; Poetini, MR; Prigol, M; Santos Musachio, EA | 1 |
1 other study(ies) available for quinoline and Parkinson Disease
Article | Year |
---|---|
7-chloro-4-(phenylselanyl) quinoline prevents dopamine depletion in a Drosophila melanogaster model of Parkinson's-like disease.
Topics: Acetylcholinesterase; Animals; Antioxidants; Dopamine; Drosophila melanogaster; Lipid Peroxidation; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Protein Carbonylation; Quinolines; Selenium; Superoxide Dismutase | 2019 |